Logo image of IMCC

IM CANNABIS CORP (IMCC) Stock Price, Quote, News and Overview

NASDAQ:IMCC - Nasdaq - CA44969Q4060 - Common Stock - Currency: USD

2.16  -0.02 (-0.92%)

After market: 2.18 +0.02 (+0.93%)

IMCC Quote, Performance and Key Statistics

IM CANNABIS CORP

NASDAQ:IMCC (2/21/2025, 8:00:01 PM)

After market: 2.18 +0.02 (+0.93%)

2.16

-0.02 (-0.92%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High8.1
52 Week Low1.61
Market Cap6.67M
Shares3.09M
Float1.73M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-26 2025-03-26/bmo
IPO11-05 2019-11-05


IMCC short term performance overview.The bars show the price performance of IMCC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

IMCC long term performance overview.The bars show the price performance of IMCC in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60 -80

The current stock price of IMCC is 2.16 USD. In the past month the price decreased by -5.26%. In the past year, price increased by 8.76%.

IM CANNABIS CORP / IMCC Daily stock chart

IMCC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 67.21 829.40B
NVO NOVO-NORDISK A/S-SPONS ADR 27.44 390.99B
JNJ JOHNSON & JOHNSON 16.25 390.76B
AZN ASTRAZENECA PLC-SPONS ADR 20.56 230.17B
MRK MERCK & CO. INC. 11.71 226.40B
NVS NOVARTIS AG-SPONSORED ADR 13.77 215.98B
PFE PFIZER INC 8.46 149.04B
SNY SANOFI-ADR 13.58 136.54B
BMY BRISTOL-MYERS SQUIBB CO 48.97 113.23B
GSK GSK PLC-SPON ADR 7.78 74.77B
ZTS ZOETIS INC 27.1 72.39B
TAK TAKEDA PHARMACEUTIC-SP ADR 31.95 44.58B

About IMCC

Company Profile

IMCC logo image IM Cannabis Corp is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario and currently employs 95 full-time employees. The company went IPO on 2019-11-05. IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The firm's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The company offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The firm's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The firm's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).

Company Info

IM CANNABIS CORP

1 Adelaide Street East, Unit 801

TORONTO ONTARIO CA

CEO: Oren Shuster

Employees: 95

Company Website: https://imcannabis.com/

Investor Relations: http://investors.imcannabis.com

Phone: 14162564202

IM CANNABIS CORP / IMCC FAQ

What is the stock price of IM CANNABIS CORP today?

The current stock price of IMCC is 2.16 USD. The price decreased by -0.92% in the last trading session.


What is the ticker symbol for IM CANNABIS CORP stock?

The exchange symbol of IM CANNABIS CORP is IMCC and it is listed on the Nasdaq exchange.


On which exchange is IMCC stock listed?

IMCC stock is listed on the Nasdaq exchange.


What is IM CANNABIS CORP worth?

IM CANNABIS CORP (IMCC) has a market capitalization of 6.67M USD. This makes IMCC a Nano Cap stock.


How many employees does IM CANNABIS CORP have?

IM CANNABIS CORP (IMCC) currently has 95 employees.


What are the support and resistance levels for IM CANNABIS CORP (IMCC) stock?

IM CANNABIS CORP (IMCC) has a support level at 1.99 and a resistance level at 2.17. Check the full technical report for a detailed analysis of IMCC support and resistance levels.


Is IM CANNABIS CORP (IMCC) expected to grow?

The Revenue of IM CANNABIS CORP (IMCC) is expected to grow by 19.16% in the next year. Check the estimates tab for more information on the IMCC EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy IM CANNABIS CORP (IMCC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does IM CANNABIS CORP (IMCC) stock pay dividends?

IMCC does not pay a dividend.


When does IM CANNABIS CORP (IMCC) report earnings?

IM CANNABIS CORP (IMCC) will report earnings on 2025-03-26, before the market open.


What is the Price/Earnings (PE) ratio of IM CANNABIS CORP (IMCC)?

IM CANNABIS CORP (IMCC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.28).


What is the Short Interest ratio of IM CANNABIS CORP (IMCC) stock?

The outstanding short interest for IM CANNABIS CORP (IMCC) is 0.95% of its float. Check the ownership tab for more information on the IMCC short interest.


IMCC Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

IMCC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IMCC. Both the profitability and financial health of IMCC have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IMCC Financial Highlights

Over the last trailing twelve months IMCC reported a non-GAAP Earnings per Share(EPS) of -3.28. The EPS decreased by -172.51% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -28.82%
ROE -216.04%
Debt/Equity 2.24
Chartmill High Growth Momentum
EPS Q2Q%-156.25%
Sales Q2Q%12.23%
EPS 1Y (TTM)-172.51%
Revenue 1Y (TTM)-2.23%

IMCC Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to IMCC. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of -314.48% and a revenue growth 19.16% for IMCC


Ownership
Inst Owners3.91%
Ins Owners39.79%
Short Float %0.95%
Short Ratio0.83
Analysts
Analysts82.86
Price TargetN/A
EPS Next Y-314.48%
Revenue Next Year19.16%